Font: Financial Modeling Prep • Aug 27, 2026
BYD Company Limited (OTC:BYDDY) is a major Chinese manufacturer specializing in electric vehicles (EVs), batteries, and electronics. As a key global player in the automotive and tech sectors, it directly competes with companies like Tesla (NASDAQ: TSLA). BYD is scheduled to release its upcoming quarterly earnings report on August 28, 2026, after the market closes.
For the quarter, Wall Street analysts anticipate an earnings per share (EPS) of $0.11. EPS is a key measure of a company's profit allocated to each share of its stock. Furthermore, revenue is estimated to be approximately $24.23 billion, indicating expectations of strong business performance during the period.
This positive outlook is supported by strong export momentum and rising EV sales. As highlighted by Seeking Alpha, BYD leads its competitor Tesla in gross profit margins and has a much larger delivery volume. These factors are expected to contribute to a robust upcoming Q2 earnings report for the company.
A significant shift in the company's growth strategy is also a key driver. As noted by Seeking Alpha, a boom in overseas sales is effectively offsetting domestic market weakness. This expansion into new regions demonstrates BYD's ability to capture significant market share outside of China and diversifies its revenue sources.
From a valuation standpoint, BYD has a trailing price-to-sales (P/S) ratio of 0.90, which compares the company's stock price to its revenues. Its debt-to-equity ratio is 0.56, indicating that its assets are financed more by equity than by debt, suggesting a relatively stable financial structure.
|
VNRX§>
VolitionRX Ltd
|
$0.50
47.70%
|
|
NVDA§>
NVIDIA Corporation
|
$227.98
8.74%
|
|
RITR§>
Reitar Logtech Holdings Limited Ordinary shares
|
$0.10
11.75%
|
|
CELU§>
Celularity Inc.
|
$2.10
138.53%
|
|
NVD§>
GraniteShares 2x Short NVDA Daily ETF
|
$3.73
-16.93%
|
|
WKSP§>
Worksport Ltd.
|
$0.63
23.53%
|
|
MERC§>
Mercer International Inc.
|
$0.39
-5.57%
|
|
INTC§>
Intel Corp.
|
$92.09
4.36%
|
|
NCPL§>
Netcapital Inc.
|
$0.54
7.55%
|
|
PPCB§>
Propanc Biopharma, Inc.
|
$2.23
108.41%
|